This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Skye Bioscience Class Action Lawsuit
Business class action

Skye Bioscience Class Action Lawsuit

Analysis based on 14 articles · First reported Nov 20, 2025 · Last updated Dec 06, 2025

Sentiment
-20
Attention
2
Articles
14
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Skye Bioscience, Inc. could lead to a significant financial liability for the company, potentially impacting its stock price and investor confidence. For investors who purchased Skye Bioscience, Inc. securities during the Class Period, there is a potential for compensation through the lawsuit.

Biotechnology Legal Services
Event Summary

Rosen Law Firm has announced and is encouraging investors to join a class action lawsuit against Skye Bioscience, Inc. The lawsuit alleges that Skye Bioscience, Inc. made materially false and misleading statements to investors between November 4, 2024, and October 3, 2025, regarding the effectiveness and prospects of its drug, nimacimab. Investors who purchased Skye Bioscience, Inc. securities during this period are encouraged to secure counsel before the January 16, 2026, lead plaintiff deadline.

Entities Involved
stock
Skye Bioscience
Skye Bioscience is the defendant in a class action lawsuit, accused of making materially false and misleading statements regarding its business, operations, and prospects, specifically concerning the effectiveness of its drug nimacimab.
Importance 100.0 Sentiment -40.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
per
Philip Kim
Importance 0.0 Sentiment 0.0
per
Lawrence Rosen
Importance 0.0 Sentiment 0.0
Relationships
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.